Bacteria in the gut microbiome drive the formation of cerebral cavernous malformations (CCMs), clusters of dilated, thin-walled blood vessels in the brain that can cause stroke and seizures. The research team’s research suggests that altering the microbiome in CCM patients may be an effective therapy for this cerebrovascular disease.